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Abstract 
Optimal procedures for the reconstitution f the transport activity of cefiibuten, a dianionic [3-1actam antibiotic, from rat kidney 
brush-border membrane were developed. The uptake activity into reconstituted proteoliposomes appeared to be particularly sensitive to 
the extraction conditions, and to the lipid composition used for reconstitution. Changes in the concentration of octyl glucoside 
significantly affected the extraction of ceftibuten transport activity, and optimal extraction was achieved at a concentration f 60 mM. 
Optimal reconstitution was achieved using a lipid composition of asolectin, cholesterol and phosphatidylserine in a w/w percent ratio of 
60:30:10, respectively, and with a lipid-to-protein ratio of 10. The uptake of ceftibuten into the resulting proteoliposomes showed 
temperature and pH dependency, was inhibitable by a range of cephem antibiotics, oligopeptides and the organic anion PAH, and was 
trans-stimulated by cephalexin and dipeptides. This reconstitution system will likely prove useful in future studies on the functional 
analysis of the peptide transport system in a purified form. 
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1. Introduction 
The use of various techniques such as isolated mem- 
brane vesicles, in vivo micro infusion techniques and 
cloning systems has contributed greatly to the characteriza- 
tion of the oligopeptide transport system in the renal 
proximal tubule [1-5]. Yet it is considered that the full 
isolation of the carrier proteins is a prerequisite for a 
complete molecular description of the function of this 
transport system. Since the main problem associated with 
the functional isolation of the carrier proteins stems from 
the instability of these proteins towards the harsh condi- 
tions during the processing for purification, the determina- 
tion of the proper conditions for the extraction and recon- 
stitution into an environment approximating the native 
membrane is an integral and important part of the strategy 
for purification. 
Until recently, several methods for the purification of 
mammalian carrier proteins have been described. Yet, for 
the oligopeptide transport systems, only one method with a 
* Corresponding author. Fax: +81 11 7561505. 
lengthy protocol was reported by Kramer et al. [6] for the 
purification of the small intestinal oligopeptide transporter. 
Since we and others [1,7,8] have reported discrepancies 
between the oligopeptide transport systems in the renal and 
the intestinal brush-border membranes, it is of importance 
to establish a protocol for the isolation of the kidney 
oligopeptide transport system(s). 
This report describes the proper conditions for the 
solubilization and functional reconstitution of the system(s) 
responsible for the transport of ceftibuten, a peptide-like 
compound, in the renal brush-border membrane. 
2. Materials and methods 
2.1. Mater ia ls  
Ceftibuten and compound V, 3-vinyl derivative of 
ceftibuten [9], were kindly donated by Shionogi (Osaka, 
Japan). Octyl glucoside (n-octyl [3-D-glucoside) was pur- 
chased from Dojindo (Kumamoto, Japan). Asolectin (L-c~- 
lecithin, commercial grade type II-S), phosphatidylserine 
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(DL-et-phosphatidyl-L-serine dipalmitoyl), phosphatidyl- 
choline (D-et-phosphatidylcholine dipalmitoyl), cholesterol 
and poly(ethylene glycol) (PEG 8000) were from Sigma 
(St. Louis, MO, USA). All other chemicals were of reagent 
grade. 
2.2. Isolation of  brush-border membrane 
The renal brush-border membrane was isolated from the 
renal cortex of the male Wistar rat by the MgZ+/EGTA 
precipitation method of Biber et al. [10] with several 
modifications as in our previous paper [7]. The final pellet 
was resuspended in a buffer composed of 100 mM manni- 
tol, 100 mM KC1, 10 mM L-alanyl-L-proline and 10 mM 
Hepes-Tris (pH 7.5). The protein concentration was ad- 
justed to 20 mg/ml,  and the suspension was stored at 
-60°C until use. 
2.3. Solubilization and reconstitution 
The procedure involved solubilization of the membrane 
with octyl glucoside in the presence of osmolytes and 
substrate, precipitation of the solubilized proteins with 
poly(ethylene glycol) (PEG 8000) and reconstitution into 
liposomal preparations. Essentially, similar procedures have 
been successfully applied for the solubilization and func- 
tional reconstitution of the placental serotonin and taurine 
transporters [11,12], and the hepatic system A-mediated 
amino acid transporter [13]. Membranes were solubilized 
with octyl glucoside (unless stated otherwise, the final 
concentration of octyl glucoside was 60 raM) at a protein 
concentration of 10 mg/ml  in the presence of 10 mM 
L-alanyl-L-proline, 1 mM DTT (dithiothreitol), 0.1 mM 
PMSF (phenylmethylsulfonyl fluoride), 7% glycerol, 3 
mM EDTA, 100 mM KCI and 20 mM Hepes-Tris (pH 
7.5). The mixture was incubated for 30 min on ice with 
slow stirring. It was then centrifuged at 100 000 X g for 45 
min. The solubilized proteins were recovered from the 
clear supernatant by mixing with one volume of 30% 
PEG-8000 solution (in the same buffer as used for solubi- 
lization but without detergent) o yield a final PEG concen- 
tration of 15%. This concentration was found from prelim- 
inary experiments with different PEG concentrations (3- 
30%) to be optimal for the recovery of the transport 
activity. The PEG-mixture was incubated with slow stir- 
ring on ice for 15 rain and then centrifuged at 220000 X g 
for 30 min. The resulting pellet was rinsed four times with 
the reconstitution buffer (100 mM mannitol, 100 mM KC1 
and 20 mM Hepes-Tris, pH 7.5) and was suspended in a 
minimal volume of the same buffer but with the addition 
of DTT and PMSF at a concentration of 1 and 0.1 raM, 
respectively. 
Liposomes (large unilamelar vesicles) for the reconstitu- 
tion were prepared with various lipid compositions by the 
reversed phase evaporation technique [14] with minor 
modifications as described previously [15]. A 50 mg lipid 
mixture was dissolved in a sufficient amount of chloro- 
form/methanol, 3:1 and added to a 50 ml round-bottomed 
flask, and solvent was removed by rotary evaporation. The 
thin layer of lipids was redissolved in 4 ml of diethyl ether 
and 1 ml of the reconstitution buffer was added. The 
mixture was sonicated in a bath-type sonicator (UT-204, 
Sharp, Osaka, Japan), under nitrogen for 5 rain at 4°C. The 
solvent was evaporated to reverse the phases of the emul- 
sion. The resulting preparation was then mixed with an 
additional volume of the reconstitution buffer (2 ml). 
Following vortex mixing, the suspension was evaporated 
to remove any traces of the organic solvent. 
Reconstitution was done by mixing the PEG-precipi- 
tated proteins with a desired volume of the liposomal 
suspension using a dounce-type glass homogenizer. The 
mixture was then frozen in liquid nitrogen and thawed at 
room temperature. The suspension was briefly sonicated (1 
rain) and diluted with 6-8 volumes of the reconstitution 
buffer. The proteoliposomes were harvested by centri- 
fuging the suspension at 85 000 × g for I h. The resulted 
pellet of proteoliposomes was suspended in a minimal 
volume of the reconstitution buffer using dounce-type 
homogenizer. The suspension was once again sonicated for 
1 min and then used for uptake measurements. 
2.4. Uptake experiment 
The uptake of ceftibuten into the prepared proteo- 
liposomes were performed at 30°C by the rapid filtration 
method [16]. Unless specified other wise, 40 txl of proteo- 
liposomes was diluted with 200 ILl of the uptake buffer 
(100 mM mannitol, 100 mM KC1, 20 mM Mes-Tris, pH 
5.5) and incubated at 30°C for the indicated times. The 
reaction was stopped with the addition of 4 ml of an 
ice-cold stop solution containing 150 mM NaCI and 20 
mM Hepes-Tris, pH 7.5. The mixture was filtered immedi- 
ately under vacuum through a Millipore filter (HAWP, 
0.45 fxm, 2.5 cm diameter). The filter was then washed 
once with 4 ml of the ice-cold stop buffer. Ceftibuten 
trapped on the filter was extracted with 300 ILl of the stop 
buffer for HPLC analysis. 
2.5. lntra-cesicular space determination 
Due to the tact that ceftibuten uptake did not reach 
equilibrium after 2 h incubation, proteoliposomes were 
prepared and used for the uptake study as in the routine 
experiment, but with the addition of ceftibuten to the 
reconstitution buffer at a concentration which is equal to 
that in the incubation medium of the uptake experiment in
order to simulate the values at equilibrium conditions. The 
apparent intra-vesicular space was calculated from the 
amount of ceftibuten trapped in the vesicles. 
2.6. SDS-polyacrylamide gel electrophoresis 
SDS/PAGE analysis was performed with an SPG-1500 
Advantec vertical electrophoresis apparatus and the 
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Laemmli [17] buffer system. A discontinuous slab gel 
(1 X 140 X 140ram) containing 10% (w/v) acrylamide and 
0.3% (w/v) N,N'-methylenebisacrylamide was used. Prior 
to SDS/PAGE the proteins from the different membrane 
preparations were precipitated by the method of Wessel 
and Flugge [18] as modified by Kramer et al. [19]. The 
dried protein precipitates were dissolved in 40-100 txl of a 
buffer containing 50 mM Tris-HC1 (pH 8.5), 2% (w/v) 
SDS, 5% (v/v) 2-mercaptoetbanol, 10% (v/v) glycerol 
and 0.002% (w/v) bromophenol blue. The mixture was 
vortexed vigorously for 5 min at room temperature and 
then was incubated at 40°C for 30 min. After the separa- 
tion of protein at 25 mA, the gel was stained with 
Coomassie brilliant blue. Molecular mass determinations 
were made by using a Sigma calibration Unit (SDS-6H, 
Sigma). 
2.7. Analytical procedures 
The detection of ceftibuten was carried out by the use 
of high-performance liquid chromatography as described 
previously [9,16,20]. Protein was measured by the method 
of Lowry et al. [21] with bovine serum albumin as the 
standard. Lipid phosphorus was measured by the ashing 
technique of Bartlett [22]. 
3. Results 
3.1. Solubilization with octyl glucoside 
Preliminary experiments with various detergents re- 
vealed that the results with octyl glucoside were most 
reproducible in terms of solubilizing capacity and transport 
activity. Fig. 1 shows the effect of varying the octyl 
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Fig. 1. Effect of detergent concentration on the solubilization and trans- 
port activity of the proteins extracted from the renal brush-border mem- 
brane. Ceftibuten (0.5 raM) steady-state (120 min) uptake activity was 
measured in the presence of an inward H + gradient (pHin = 7.5, PHou t = 
5.5) after reconstitution i asolectin vesicles. Each value is the mean with 
S.E.M. (n = 4 or 5). The error bars are smaller than the size of the 
symbols. 
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Fig. 2. Uptake of ceftibuten (0.5 raM) by proteoliposomes prepared from 
reconstituting the PEG-precipitated proteins with various lipid composi- 
tions. Uptake was measured in the presence of an inward H + gradient 
(pHi, = 7.5, pHo. t = 5.5). Each value is the mean with S.E.M. (n = 4). 
The some error bars are smaller than the size of the symbols. Aso = 
asolectin, CH = cholesterol, PS = phosphatidylserine, and PE = 
phosphatidylethanolamine. 
glucoside concentration on the total protein solubilization 
and the uptake activity of ceftibuten into proteoliposomes 
prepared with asolectin. These results show that the total 
membrane protein solubilization improved as the octyl 
glucoside concentration was increased, until it reached a 
plateau at approx. 50 mM octyl glucoside. However, the 
uptake activity of ceftibuten decreased markedly when the 
detergent concentration reached 100 mM. For this reason, 
an octyl glucoside concentration of 60 mM was adopted as 
an optimai concentration for the subsequent experiments. 
3.2. Effect of lipid composition on reconstitution of 
cef'tibuten transport activity 
Various lipid mixtures were tested for the reconstitution 
of ceftibuten transport activity (Fig. 2). The addition of 
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Fig. 3. Apparent intra-vesicular volume of proteoliposomes prepared from 
reconstituting the PEG-precipitated proteins with various lipid mixtures at 
a lipid-to-protein ratio of 10. Each value is the mean with S.E.M. (n = 5). 
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Fig. 4. SDS/PAGE analysis of proteoliposomes prepared from reconsti- 
tuting the PEG-precipitated proteins with various lipid mixtures at a 
lipid-to-protein ratio of 10. BBM, brush-border membranes (10 ~g); Aso, 
proteoliposomes with asolectin only (5 ~g); Aso:CH, proteoliposomes 
with the mixture Aso/CH = 90:10 (5 p~g); Aso:CH:PS, proteoliposomes 
with the mixture Aso /CH/PS  = 60:30:10 (5/,zg); PC:PE:CH:PS, proteo- 
liposomes with the mixture PC/PE /CH/PS  = 40:30:20:10 (5 p~g). 
cholesterol to the reconstitution mixture enhanced the ini- 
tial and the maximal accumulation of ceftibuten, indicating 
an increase in the population of the transport competent 
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Fig, 5. Effect of lipid-to-protein ratio on the steady-state (120 rain) uptake 
of ceftibuten (0.5 raM) by proteoliposomes prepared from reconstituting 
the PEG-precipitated proteins (fixed concentration) with a lipid mixture 
of Aso /CH/PS  = 60:30:10 at different ratios. Uptake was measured in 
the presence of an inward H + gradient (pHi, = 7.5, pH,,0t = 5.5). Each 
value represents he mean with S.E.M. (n = 4). The some error bars are 
smaller than the size of the symbols. 
vesicles and/or the activity of the carrier protein(s) (the 
number of turn over per time unit) in this liposomal 
preparation. However, optimal level of uptake was ob- 
served when proteoliposomes with a lipid mixture of 60% 
asolectin, 30% cholesterol and 10% phosphatidylserine 
(w/w) were used. Proteoliposomes of this composition 
had an initial uptake rate of 30 pmol ceftibuten/~mol 
phosphorus per rain, with a 120 rain-uptake of approx. 400 
pmol ceftibuten/p~mol phosphorus. These values are about 
4- and 3-fold, respectively, greater than those obtained 
using proteoliposomes prepared from asolectin alone. As 
shown in Fig. 3, it is evident hat the addition of choles- 
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Fig. 6. Temperature dependency of the uptake of ceftibuten (0.5 mM) by proteoliposomes prepared from reconstituting the PEG-precipitated proteins in a 
lipid mixture of Aso /CH/PS  = 60:30:10 at a lipid-to-protein ratio of 10. Uptake was measured in the presence of an inward H + gradient (pHin = 7.5, 
pHou t = 5.5). Each value is the mean _+ S.E.M. (n = 4). The inset represents he early time profiles of ceftibuten uptakes at both temperatures. 
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Table 1 
Inhibitory effects of dipeptides, peptide-related compounds and FCCP Oll the uptake of ceftibuten (0.5 raM) by proteoliposomes prepared from 
reconstituting the PEG-precipitated proteins with a lipid mixture of Aso /CH/PS  = 60:30:10 at a lipid-to-protein ratio of 10 
Type of inhibitor 5-min uptake 120-min uptake 
(pmol /mg protein) (pmol /mg protein) 
Control (without inhibitor) 675.80 _+ 
FCCP 563.79 _+ 
Compound V 207.48 ± 
t~-Carnosine 371.69 ± 
Hippurylphenyllactic acid 522.65 ± 
L-Alanyl-L-alanine 564.03 _+ 
D-Alanyl-D-alanine 641.80 _+ 
D-Cephalexin 385.37 -t- 
PAH 482.88 ± 
L-Valyl-L-proline 500.09 _+ 
16.18 
41.09 * 
29.18 ** 
35.18 *" 
13.88 * * 
33.22 * 
54.71 
35.65 ** 
29.37 * * 
19.47 ~ * * 
1386.39 ± 66.30 
1087.05 ± 119.81 * 
701.73 ± 88.40 * 
1315.74± 50.71 
872.28 ± 26.60 
1092.96 ± 95.93 * 
1243.58 ± 28.16 
926.30 ± 41.04 * 
1426.59 ± 25.83 
833.84± 11.46 * 
FCCP was added at a concentration of 50 IxM. Other inhibitors were added at a concentration of 10 mM. Data were calculated after correction for the 
non-specific uptake (uptake at 4°C). Each value is the mean _+ S.E.M. (n = 6). * P < 0.05, ~ * * P < 0.001: significantly different from control. 
terol alone resulted in a significant increase in the intra- 
vesicular volume, indicating probably an enhancement in 
the vesicle fusion during the freeze-thaw step as reported 
by several authors [23,24]. However, when phos- 
phatidylserine was added the intra-vesicular volume was 
brought down to the original value with asolectin alone. 
SDS-PAGE analysis revealed that the four liposomal 
preparations contained the same bands without any spe- 
cific enrichment for certain proteins (Fig. 4). Therefore, it
is likely that the enhancing effect of phosphatidylserine s 
due to a direct effect on the reconstituting capacity (the 
number of the carriers inserted per vesicle), and/or to an 
effect on the intrinsic activity of the carrier proteins (turn- 
over number). We also tested another preparation of artifi- 
cial lipid mixture (phosphatidylcholine/phosphati- 
dy lser ine /phosphat idy le thano lamine/cho les tero l ,  
40:10:30:20) mentioned by the same author as the most 
effective combination for reconstituting nucleoside trans- 
porters. However, in the present study, this preparation 
failed to prove optimal for the reconstitution of ceftibuten 
transporter(s). 
3.3. Effect of lipid-to-protein ratio on reconstitution of 
ceftibuten transport 
Increasing the lipid-to-protein ratio from 2 to 100, while 
keeping the PEG-precipitated protein concentration con- 
stant, resulted in a parallel increase in the percentage of the 
total incorporated protein. This increase was accompanied 
with a non-linear increase in the 120 rain-uptake of 
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Fig. 7. Trans-stimulation effect of D-cephalexin and L-val-L-pro on the initial (5 min) uptake of ceftibuten (0.312 mM) by proteoliposomes prepared from 
reconstituting the PEG-precipitated proteins in a lipid mixture of Aso /CH/PS  = 60:30:10 at a lipid-to-protein ratio of 10.Vesicles (20 txl) were preloaded 
with 5 ixl of counter-substrate (25 raM) for 3 h at 30°C to give a final intra- and extra-vesicular concentration of 5 and 0.24 mM, respectively. Uptake was 
then initiated by incubating the preloaded vesicles with 500 txl of ceftibuten solution (0.312 raM) in the absence of H + gradient (pHi, = pHou t = 5.5). 
Each value is the mean with S.E.M. (n = 5). * P < 0.001, significantly different from control. 
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ceftibuten, reaching a plateau at a ratio of 12:1 or more 
(Fig. 5). A ratio of 10:1 was adopted for the subsequent 
routine experiments. 
3.4. Functionality and substrate specificity of the estab- 
lished liposomal preparation 
Following the establishment of the optimal conditions 
for solubilization and reconstitution of ceftibuten trans- 
porter(s), the functionality and substrate specificity of the 
carrier protein(s) were assessed. Firstly, the temperature 
dependence of ceftibuten uptake by the optimized prepara- 
tion was examined. As shown in Fig. 6, the uptake at 4°C 
was significantly lower than that at 30°C, indicating an 
involvement of a transport process rather than a binding 
phenomenon. Secondly, the inhibitory effects of dipep- 
tides, cephem antibiotics, FCCP, and PAH were examined 
in the presence of an inwardly directed proton gradient. As 
shown in Table 1, the proteoliposomal preparation of this 
study was characterized with an inhibition spectrum which 
is similar to that for the native renal brush-border mem- 
brane vesicles [20]. Furthermore, abolishing the inwardly 
directed proton gradient by FCCP, a protonophore, signifi- 
cantly inhibited the steady-state (but not the initial) uptake, 
indicating that the proton-mediated transport process into 
the proteoliposomes is very slow compared with the origi- 
nal membrane vesicles. Finally, to further confirm the 
viability of the carrier protein(s) responsible for ceftibuten 
transport, trans-stimulation study was made. In the pres- 
ence of D-cephalexin and L-valyl-L-proline, uptake was 
increased 200% and 150%, respectively (Fig. 7). This 
result extends the evidence of the functionality of the 
reconstituted carrier protein(s) in this preparation. 
4. Discussion 
The reconstitution protocol described here is both sim- 
ple and reliable. It permits the rapid reconstitution of the 
transport activity of ceftibuten with characteristics similar 
to those described in the original brush-border membrane 
vesicles. 
4.1. Effect of solubilization conditions 
The proper concentration f octyl glucoside used in this 
study affords the solubilization of many of the transport 
properties characteristic of the native membrane trans- 
porter(s). In addition, the presence of osmolytes (glycerol 
and mannitol) and L-alanyl-L-proline (a substrate for the 
peptide transporters) permits good protection for the pro- 
teins of interest. The addition of osmotytes and substrate 
was stemmed from the result of many trials and errors 
made during the search for the optimal conditions of
solubilization (data not shown). There also are many ex- 
amples in the literature of the protective ffects of os- 
molytes and substrates on the carrier proteins [25,26]. 
4.2. Effect of lipid composition 
The present study assessed the impact of lipids such as 
cholesterol and phosphatidylserine on the functional char- 
acteristics of the reconstituted transporter(s). Supplement- 
ing the crude asolectin mixture with cholesterol and phos- 
phatidylserine l d to greater uptake values. 
As described in the result Section 3.2, the presence of 
cholesterol and phosphatidylserine in asolectin prepara- 
tions did not lead to a dramatic alteration in the intra-vesic- 
ular space, indicating an involvement of factors other than 
vesicle volume for enhancing the transport activity. It is 
worth noting that similar lipid mixture has been previously 
mentioned by Hammond [27] to be convenient for the 
reconstitution of the nucleoside transporters in Ehrlich cell 
plasma membrane. 
4.3. Effect of lipid-to-protein ratio 
The transport activity of ceftibuten was dependent upon 
the amount of lipid added and increased with additional 
lipid to a point where all the transport competent protein(s) 
were inserted into the liposomes. This non-linear fashion 
of transport increase did not keep pace with the incorpora- 
tion of the total proteins, where an almost linear correla- 
tion with lipid amount was observed, indicating that the 
transport competent protein(s) tend to associate with the 
liposomal membrane in a more specific fashion than other 
proteins present in the bulk solution. 
4.4. Viability of the reconstituted carrier protein(s) 
Proton-dependency, electrogenicity, and inhibitory ef- 
fect of the derivatives on the transport observed in the 
native brush-border membrane vesicles were in agreement 
with the results obtained from reconstituted preparation of 
the present study. However, the uptake of ceftibuten i  this 
study was characterized with a slower uptake rate. The 
slower uptake rate is likely to be due to the rigidity and 
impermeability of the liposomal membrane. Similar obser- 
vations have been also reported for the phosphate and 
glucose transporters after solubilization and reconstitution 
from the renal brush-border membrane [28,29]. It remains 
unclear which peptide transporter PepT1 [30,31] or PepT2 
[31] has been reconstituted in this study. However, it is 
probable that both of transporters were reconstituted in the 
proteoliposomes although this will require further investi- 
gation. 
4.5. Conclusion 
The present study demonstrates anefficient method for 
the functional solubilization and reconstitution of the car- 
rier system(s) responsible for the transport of ceftibuten 
and other peptide-related compounds in the renal brush- 
border membrane. The simple and reliable solubilization 
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and reconstitution procedures presented here would there- 
fore prove useful in future studies aiming at the purifica- 
tion and identification of the peptide carriers, a salient goal 
for understanding the transport mechanism of peptides at 
the molecular level. 
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